These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1657 related items for PubMed ID: 28369882

  • 21. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.
    J Natl Cancer Inst; 2009 Aug 19; 101(16):1120-30. PubMed ID: 19648510
    [Abstract] [Full Text] [Related]

  • 22. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.
    Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S.
    Int J Cancer; 2015 Jun 15; 136(12):2752-60. PubMed ID: 25043222
    [Abstract] [Full Text] [Related]

  • 23. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [Abstract] [Full Text] [Related]

  • 24. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK.
    PLoS One; 2014 Nov 22; 9(2):e88323. PubMed ID: 24505474
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.
    Eur J Cancer; 2015 Sep 22; 51(13):1732-41. PubMed ID: 26121913
    [Abstract] [Full Text] [Related]

  • 26. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK.
    J Adolesc Health; 2010 Apr 22; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [Abstract] [Full Text] [Related]

  • 27. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.
    Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147
    [Abstract] [Full Text] [Related]

  • 28. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2013 Mar 03; 13():114. PubMed ID: 23452957
    [Abstract] [Full Text] [Related]

  • 29. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM.
    Vaccine; 2008 Jan 10; 26(2):250-6. PubMed ID: 18068276
    [Abstract] [Full Text] [Related]

  • 30. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
    Otter S, Whitaker S, Chatterjee J, Stewart A.
    Clin Oncol (R Coll Radiol); 2019 Feb 10; 31(2):81-90. PubMed ID: 30385006
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Age-specific occurrence of HPV16- and HPV18-related cervical cancer.
    de Sanjose S, Wheeler CM, Quint WGV, Hunt WC, Joste NE, Alemany L, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group, Myers ER, Castle PE.
    Cancer Epidemiol Biomarkers Prev; 2013 Jul 19; 22(7):1313-1318. PubMed ID: 23632816
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
    Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N.
    Vaccine; 2009 Jan 29; 27(5):636-9. PubMed ID: 19056450
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa.
    Clifford GM, de Vuyst H, Tenet V, Plummer M, Tully S, Franceschi S.
    J Acquir Immune Defic Syndr; 2016 Nov 01; 73(3):332-339. PubMed ID: 27331659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 83.